Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-06 9:47 pm Sale | 2026-04-06 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 12,692,841 9.900% | -2,973,890 (-18.98%) | Filing History |
| 2026-02-17 6:06 pm Sale | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | ORBIMED ADVISORS LLC | 3,230,797 2.600% | -207,016 (-6.02%) | Filing History |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Point72 Asset Management, L.P. | 5,014,617 4.000% | -2,816,808 (-35.97%) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-10-27 | 13G | ADC THERAPEUTICS SA SHS ADCT | TCG Crossover GP II, LLC | 11,390,175 9.200% | 11,390,175 (New Position) | Filing History |
| 2026-02-17 4:15 pm Unchanged | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 15,666,731 12.700% | 0 (Unchanged) | Filing History |
| 2026-02-13 4:31 pm Purchase | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 8,477,338 6.800% | 1,281,964 (+17.82%) | Filing History |
| 2025-11-13 7:38 pm Sale | 2025-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 7,195,374 5.800% | -2,422,157 (-25.18%) | Filing History |
| 2025-11-05 4:05 pm Purchase | 2025-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Oaktree Capital Group Holdings GP, LLC | 4,673,441 4.140% | 392,781 (+9.18%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 15,666,731 14.000% | -2,486 (-0.02%) | Filing History |
| 2025-06-17 5:28 pm Purchase | 2025-06-16 | 13G | ADC THERAPEUTICS SA SHS ADCT | Point72 Asset Management, L.P. | 7,831,425 7.000% | 7,831,425 (New Position) | Filing History |
| 2025-05-19 7:40 pm Purchase | 2025-05-15 | 13G | ADC THERAPEUTICS SA SHS ADCT | HPWH TH AG | 9,788,944 9.610% | 1,235,844 (+14.45%) | Filing History |
| 2025-04-24 10:50 am Sale | 2025-03-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | BlackRock Inc. BLK | 4,913,153 5.000% | -98,704 (-1.97%) | Filing History |
| 2025-02-14 4:35 pm Purchase | 2024-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | ORBIMED ADVISORS LLC | 3,437,813 3.600% | 3,437,813 (New Position) | Filing History |
| 2025-02-03 6:10 pm Purchase | 2024-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | BlackRock Inc. BLK | 5,011,857 5.200% | 5,011,857 (New Position) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 15,669,217 16.200% | 340,900 (+2.22%) | Filing History |
| 2024-11-13 08:58 am Sale | 2024-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 9,617,531 9.950% | -9,486 (-0.10%) | Filing History |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 9,627,017 9.960% | 3,155,217 (+48.75%) | Filing History |
| 2024-05-03 9:31 pm Purchase | 2024-04-25 | 13G | ADC THERAPEUTICS SA SHS ADCT | Oaktree Capital Group Holdings GP, LLC | 4,280,660 5.190% | 4,280,660 (New Position) | Filing History |
| 2024-04-25 4:10 pm Sale | 2024-04-23 | 13D | ADC THERAPEUTICS SA SHS ADCT | AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.700% | -4,074,829 (-64.37%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 15,328,317 18.800% | 1,763,068 (+13.00%) | Filing History |